Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

AAttovia Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
A

Attovia Therapeutics, Inc.

$20.83Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $450K. Net result −$20.69M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $450K. Running result $450K. Revenue: $450K.
  • Cost of revenue: $0. Running result $450K.
  • Gross profit: $450K. Running result $450K.
  • Research and development (including related party amounts of $178 and $34 for the three months ended June 30, 2026 and 2025, respectively, and $238 and $41 for the six months ended June 30, 2026 and 2025, respectively): −$18.95M. Running result −$18.5M.
  • General and administrative (including related party amounts of $0 for the three months ended June 30, 2026 and 2025, and $0 and $239 for the six months ended June 30, 2026 and 2025, respectively): −$3.31M. Running result −$21.8M.
  • Operating income: −$21.8M. Running result −$21.8M.
  • Other income: $1.12M. Running result −$20.69M.
  • Pre-tax loss: −$20.69M. Running result −$20.69M.
  • Income tax benefit: $0. Running result −$20.69M.
  • Net loss: −$20.69M. Running result −$20.69M.